Patient Guide: Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 40 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04740307
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced Hepatocellular Carcinoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 40 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Baltimore, Maryland
  • New York, New York
  • • And 37 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily